While competitive bidding is intended to save taxpayer money, the current framework creates a dangerous opening for Chinese ...

Real-time continuous glucose monitoring (CGM) improves blood glucose management in adults with type 2 diabetes managed with basal insulin.

Monitoring a constant stream of data doesn’t help people make health-related decisions and can lead to confusion and needless ...

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced ...

The Middle East and Africa Continuous Glucose Monitoring (CGM) market is set for growth, driven by increasing diabetes rates, technological advancements, and healthcare awareness. Projected to rise ...

In this Managed Healthcare Executive Between the Lines video series, Estay Greene, Pharm.D., MBA, and Victoria Bouhairie, M.D ...

Glucotrack’s Continuous Blood Glucose Monitor is an investigational, fully implantable system that continually tracks blood glucose via a blood-based sensor. The device is limited by U.S. law to ...

Keeping tabs on blood sugar throughout the day used to be the exclusive domain of people with diabetes. But in 2026, anyone ...

As diabetes continues to affect millions across Europe, the region’s healthcare sector is rapidly shifting towards solutions that improve disease management and patient outcomes. Among the most ...

Type 2 diabetes patients who wear a continuous glucose monitor have better blood sugar control than those who rely on ...

A major clinical trial has found that continuous glucose monitoring can improve blood sugar control in adults with type 2 diabetes treated with basal insulin. The study compared real-time CGM with ...